NASDAQ:CTMX

CytomX Therapeutics SEC Filings & 10K Form

$5.44
+0.19 (+3.62 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.27
$5.46
50-Day Range
$4.32
$5.89
52-Week Range
$4.28
$10.05
Volume329,943 shs
Average Volume888,817 shs
Market Capitalization$354.45 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69

CytomX Therapeutics (NASDAQ:CTMX) SEC Filings

DateFilerForm TypeView
08/18/2021
11:15 PM
CytomX Therapeutics (Filer)
Form EFFECT
08/16/2021
8:54 PM
CytomX Therapeutics (Filer)
Form S-3/A
08/13/2021
4:22 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
3:19 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2021
2:51 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:48 PM
CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:47 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:46 PM
CytomX Therapeutics (Issuer)
SCARLETT JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:45 PM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:44 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:43 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
5:43 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
8:49 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
12:10 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
12:08 PM
Campoy Carlos (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
12:07 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:12 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2021
4:19 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
04/28/2021
3:36 PM
CytomX Therapeutics (Filer)
Form DEFA14A
04/28/2021
3:32 PM
CytomX Therapeutics (Filer)
Form DEF 14A
04/02/2021
4:37 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
3:17 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
4:01 PM
Campoy Carlos (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
4:00 PM
CytomX Therapeutics (Issuer)
HANNAH ALISON L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:59 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
3:27 PM
CytomX Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/18/2021
6:55 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
CytomX Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
4:27 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
02/10/2021
9:46 AM
CytomX Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/29/2021
3:30 PM
CytomX Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
01/26/2021
4:20 PM
CytomX Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
01/25/2021
4:18 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2021
4:04 PM
CytomX Therapeutics (Filer)
Form 424B5
01/19/2021
4:12 PM
CytomX Therapeutics (Filer)
Form 424B5
01/19/2021
4:09 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2020
6:52 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
4:15 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
CytomX Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2020
3:15 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
3:41 PM
CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:40 PM
CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2020
3:59 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:58 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
3:57 PM
Campoy Carlos (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
3:13 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
3:15 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
3:53 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:06 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/19/2020
11:03 AM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
2:01 PM
CytomX Therapeutics (Issuer)
SCARLETT JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:12 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:09 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:08 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:07 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:06 PM
CytomX Therapeutics (Issuer)
Fuchs Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:54 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
5:49 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2020
5:48 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/28/2020
3:15 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
7:01 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
4:25 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
4:29 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G
02/27/2020
4:26 PM
CytomX Therapeutics (Filer)
Form 424B5
02/21/2020
11:34 AM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
4:20 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
5:41 PM
CytomX Therapeutics (Issuer)
Kavanaugh William Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:39 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:38 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:37 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
2:44 PM
CytomX Therapeutics (Issuer)
HANNAH ALISON L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
2:43 PM
CytomX Therapeutics (Issuer)
HANNAH ALISON L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2020
9:23 AM
CytomX Therapeutics (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G
01/27/2020
1:03 PM
CytomX Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/16/2019
3:20 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
3:11 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
6:01 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
5:59 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/29/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
4:19 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
3:20 PM
CytomX Therapeutics (Filer)
Form 8-K/A
06/21/2019
3:14 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
1:06 PM
CytomX Therapeutics (Issuer)
SCARLETT JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:05 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:04 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:03 PM
CytomX Therapeutics (Issuer)
Fuchs Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:02 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:01 PM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:06 PM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:04 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:22 PM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2019
5:06 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
11:27 AM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4/A
05/09/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:06 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
7:00 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:58 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2019
2:49 PM
CytomX Therapeutics (Filer)
Form DEFA14A
04/26/2019
2:46 PM
CytomX Therapeutics (Filer)
Form DEF 14A
This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.